Helix and Recursion Pharmaceuticals Drive Drug Discovery Innovation Through Clinico-Genomic Data

Go back to Helix and Recursion Pharmaceuticals Drive Drug Discovery Innovation Through Clinico-Genomic Data
(NASDAQ: RXRX) Delayed: 4.27 -0.36 (7.78%)
Previous Close $4.63    52 Week High $ 
Open $4.51    52 Week Low $ 
Day High $4.60    P/E N/A 
Day Low $4.23    EPS $ 
Volume 40,723,529